Valve to myocardium tension members device and method

Information

  • Patent Grant
  • 8226711
  • Patent Number
    8,226,711
  • Date Filed
    Friday, July 1, 2005
    19 years ago
  • Date Issued
    Tuesday, July 24, 2012
    12 years ago
Abstract
A device for heart valve repair including at least one tension member having a first end and second end. A basal anchor is disposed at the first end of the tension member and a secondary anchor at the second end. The method includes the steps of anchoring the basal anchor proximate a heart valve and anchoring the secondary anchor at a location spaced from the valve such that the chamber geometry is altered to reduce heart wall tension and/or stress on the valve leaflets.
Description
BACKGROUND OF THE INVENTION

The present invention pertains generally to the field of heart valve repair. More specifically, the present invention pertains to a device and method for the reduction of myocardial wall tension and the repair of mitral valve insufficiency.


Dilated cardiomyopathy is often accompanied by mitral valve insufficiency. There are several reasons for the presence of mitral valve insufficiency associated with a dilated heart. First, chamber dilation and associated high wall stresses increase the diameter of the mitral valve annulus. Additionally, as the heart dilates, the positioning of the papillary muscles is altered. Papillary muscles and chordae in a dilated heart will have moved both radially away and down from the mitral valve. This rearrangement of the vascular apparatus and enlargement of the annulus prevent the valve from closing properly.


Currently mitral valve insufficiency is treated by either repairing or replacing the valve. Surgical procedures used to repair the valve including ring posterior annuloplasty which consists of sewing a C or D-shaped ring around the posterior leaflet of the mitral valve and drawing in the annulus, reducing its previously enlarged diameter. Another method is to approximate the anterior and posterior mitral leaflets (Alfieri repair) by placing one suture through the center of both leaflets. This gives the valve a figure 8-shaped appearance when the valve is opened. When the mitral valve is replaced, the original leaflets are removed and the chordae are cut. An artificial valve consists of mechanical or tissue leaflets suspended on struts attached to a metal stent, and is sutured into place on the mitral annulus.


It has been argued that valve repair is preferable to valve replacement if the leaflet-chordae-papillary connections can be maintained. Heart wall stress will increase if the chordae are cut during valve replacement. It has been shown that by severing the chordae there can be 30 percent (30%) reduction in chamber function. Mitral valve replacement has high morality in very sick, chronic heart failure patients.


SUMMARY OF THE INVENTION

The present invention pertains to a device and method for mitral valve repair. The mitral valve is generally defined as its leaflets or cusps, but in reality, it actually consists of the entire left ventricle chamber. By creating an improved chamber geometry, both chamber and valve function will be improved. The device of the present invention and method for valve repair/replacement can include treatment for chronic heart failure by reducing left ventricular wall tension.


In one embodiment of the present invention, the valve repair device includes an elongate tension member having a first end and second end. The basal anchor is disposed at the first end and the secondary anchor is disposed at the second end.


The basal anchor could include a pad and annuloplasty ring or the like. Alternately an artificial heart valve could serve as the basal anchor.


Tension members can be substantially rigid or substantially flexible. The secondary anchor can include a hook-shaped papillary muscle tissue loop, screw-shaped tissue anchor or transmural anchor pad.


The method of the present invention providing a tension member having a first end and a second end. The tension member has a basal anchor at the first end and a secondary anchor at the second end. The basal anchor is anchored proximate to the valve such that the tension member is disposed in the chamber. The secondary anchor is anchored to a portion of the heart spaced from the basal anchor such that the tension member is under tension and the geometry of the chamber has been altered by placement of the tension member.


The basal anchor can include an artificial heart valve, annuloplasty ring or the like. The secondary anchor can be anchored to a papillary muscle or transmurally anchored.


More than one tension member can be used. Additionally, a transverse tension member can be placed across the chamber generally perpendicular to the other tension members to further alter the geometry of the heart, reducing wall stress and improving chamber performance.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a transverse cross section of the left ventricle of a human heart taken from FIG. 2;



FIG. 2 is a vertical cross section of the left ventricle of a human heart;



FIG. 3 is a modified, transverse, cross section of the left ventricle of a human heart taken from FIG. 4;



FIG. 4 is modified, vertical cross section of a human heart, modified by a device in accordance with the present invention;



FIG. 5 is a cross section of an insufficient mitral valve of a left ventricle of a human heart;



FIG. 6 is a cross section of a repaired valve and device in accordance with the present invention;



FIG. 7 is an embodiment of the device of the present invention;



FIG. 8 is an alternate embodiment of a device in accordance with the present invention;



FIG. 9 is yet another alternate embodiment of a device in accordance with the present invention;



FIG. 10 is yet another alternate embodiment of the device in accordance with the present invention;



FIG. 11 is yet another alternate embodiment of a device in accordance with the present invention;



FIG. 12 is a view of a basal anchor for the device of the present invention;



FIG. 13 is a suture ring serving as a basal anchor for the device of the present invention;



FIG. 14 is a replacement valve serving as a anchor for the device of the present invention;



FIG. 15 is a top view of an alternate embodiment of a suture ring acting as an anchor for the device of the present invention;



FIG. 16 is a side view of the suture ring of FIG. 15;



FIG. 17 is a view of an alternate embodiment of a suture ring which can act as basal anchor for the device of the present invention;



FIG. 18 is a view of yet another alternate embodiment of a suture ring which can act as a basal anchor for the present invention;



FIG. 19 is a embodiment of a secondary anchor for the device of the present invention;



FIG. 20 is a view of an alternate embodiment of a secondary anchor for the device of the present invention; and



FIG. 21 is yet another embodiment of a secondary anchor for the device of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Referring now the drawings wherein like reference numerals refer to like elements throughout the several views, FIG. 1 shows a transverse cross section of the left ventricle 10 of a failing heart taken from FIG. 2. The papillary muscles 12 are shown in cross section. FIG. 2 is a vertical cross section of human heart 10. A mitral valve is disposed near the top of left ventricle 10. Mitral valve 14 includes two leaflets or cusps 16. Chordae 18 extend between leaflets 16 and papillary muscles 12.



FIG. 3 is a cross section of heart 10 modified from that shown in FIG. 1 by placement of valve repair device 20 in accordance with the present invention as shown in FIG. 4. FIG. 4 is a vertical cross section of left ventricle 10 with geometry modified by device 20. In this embodiment of the invention, device 20 includes a basal anchor 22 such as an annuloplasty or suture ring sewn proximate the annulus of valve 14. Extending from basal anchor 22 are elongate tension members 24. Each have a first end connected to basal anchor 22 and a second end anchored to papillary muscles 12 or the heart wall.


As can be seen in FIGS. 3 and 4, both the transverse radius and vertical dimension of left ventricle 10 has been reduced in comparison to that of FIGS. 1 and 2 by drawing papillary muscles 12 toward valve 14 with tension members 24. This change in geometry reduces heart wall stress and consequently increasing chamber function. Valve function is also improved as explained in more detail by reference to FIGS. 5 and 6.



FIG. 5 is a generally vertical cross section of an insufficient mitral valve of a heart suffering from chronic heart failure. In this case as the failing heart has dilated, papillary muscle 12 has been drawn away from mitral valve 14. The chordae connections between papillary muscles 12 and valve 14 in turn draws leaflets 16 apart such that during the normal cardiac cycle, leaflets 16 may not completely close. Thus, an opening 26 is left between leaflets 16 throughout the cardiac cycle. Opening 26 will allow blood to leak, reducing chamber efficiency.



FIG. 6 is a view of the mitral valve 14 of FIG. 5 which has been modified by placement of valve repair device 20 as shown. Suture ring 22 is sewn proximate the annulus of valve 14, as known to those skilled in the use of suture rings. The annulus of valve 14 can be decreased in size by drawing the annulus toward the suture ring by the sutures used to connect ring 22 to the valve. Drawing the annulus of valve 14 toward suture ring 22 will help to eliminate opening 26. Tension member 24 is then anchored to papillary muscle 12 such that papillary muscle 12 is drawn toward valve 14. Whether or not the suture ring alone is sufficient to eliminate opening 26, drawing papillary muscle 12 toward valve 14 will provide additional stress relief on leaflet 16 promoting complete closure of valve 14. Drawing papillary muscle 12 toward 14 also reduces heart wall stress and increases chamber efficiency as discussed previously.



FIG. 7 is a highly simplified view of left ventricle 10 and valve repair device 20 as shown in FIG. 4. It can be noted that tension members 24 extend from basal anchor 22 to an adjacent papillary muscle 12. In contrast, FIG. 8 is a similar cross sectional view of left ventricle 10, but a valve repair device 120 is placed such that its tension members 124 extend between a basal anchor 122 and a papillary muscle 12 transversely opposite the point at which tension member 124 is connected to basal anchor 122. This arrangement, as opposed to that shown in FIG. 7, can increase the transverse component of the tension force in tension members 124 relative to the vertical component of that tensile force.



FIG. 9 shows yet another embodiment of the valve repair device in accordance with the present invention referred to by numeral 220. In this embodiment, device 220 is disposed in left ventricle 10 in a manner similar to that of device 20 shown in FIG. 7 in that tension members 224 of device 220 extend from a basal anchor 222 to an adjacent secondary anchor point. The secondary anchor point is established by transverse extension of a tension member 225 across left ventricle 10. Tension member 225 is anchored transmurally to the heart wall at its opposite ends by pads 227. In turn, tension members 224 are anchored or connected to tension member 225.


Tension member 225 can be used to further alter the geometry of left ventricle 10 in a manner disclosed in U.S. Pat. No. 5,961,440, entitled “HEART WALL TENSION REDUCTION APPARATUS AND METHOD”, which was filed on Sep. 18, 1997 and is incorporated herein by reference.



FIG. 10 shows yet another embodiment of a valve repair device in accordance with the present invention referred to by numeral 320. This embodiment includes a basal anchor 322 and tension members 324 and a transverse tension member 325 having anchor pads 327 similar to those of device 220. With respect to device 320, however, tension members 324 are crossed similar to those of device 120 of FIG. 8 to increase the horizontal component relative to the vertical component of the tensile force in tension member 324.



FIG. 11 is a yet another embodiment 420 of the valve repair device of the present method. Valve repair device 420 includes a basal anchor 422 and tension members 424. Tension members 424 are disposed in an arrangement similar to tension members 24 of device 20 shown in FIG. 7 except that tension members 424 are anchored transmurally by pads 427 rather than into papillary muscles 12. The relatively greater thickness of tension members 424 shown in FIG. 11, as compared to tension members 24 shown in FIG. 7, merely illustrates that the tension members can be substantially rigid or in the case of tension members 24, substantially flexible. It should be understood, however, that in any of the embodiments shown herein, the tension members could be advantageously formed to be substantially flexible or substantially rigid.



FIG. 12 is a top or posterior view of valve 14. In this embodiment, the basal anchor for the valve repair device is shown as discrete pads 28 which can be sewn to the posterior side of valve 14. Tension members 24 are shown extending from respective pads 28 into the left ventricle.



FIG. 13 is the same view of valve 14 as FIG. 12. In FIG. 13, however, the basal anchor 22 is shown as a crescent-shaped suture ring. Tension members 24 extends from basal anchor 22 through valve 14 into the left ventricle.



FIG. 14 is a side view of an artificial heart valve 30. If it is necessary to replace the valve rather than merely repair it, artificial valve 30 can be used as a basal anchor for tension members 24.



FIG. 15 is a top view of an alternate embodiment of a suture ring basal anchor 32. Ring 32 has a crescent shape and a pylon 34 extending through the mitral valve. FIG. 16 is a side view of suture ring 32 showing tension members 24 attached to pylon 34.


Tension members 24 preferably extend through the tissue of valve 14 rather than through the valve opening. It can be appreciated, however, that tension members 24 could be disposed through the valve opening. In the case of the embodiment of FIGS. 15 and 16, however, pylon 34 would be disposed through the valve opening. Tension members 24 associated with pylon 34 would be disposed on the opposite side of valve 14 from suture ring 32. Pylon 34 would preferably be disposed through the valve opening rather than the tissue forming valve 14.



FIGS. 17 and 18 are yet additional alternate embodiments of suture rings which can be used as basal anchors in accordance with the present invention. The shape of the rings is selected such that as they are sewn into place on valve 14, the sutures can be used to draw tissue toward the inside of the ring, thus reducing the transverse and/or vertical cross sectional area of the associated heart chamber. This will advantageously reduce heart wall stress which is of particular benefit if the patient has a failing heart.


It can be appreciated that tension members 24 can be fixably or releasably attached to the basal anchor. Preferably, the tension members are fixably attached to the basal anchor during the valve repair procedure.



FIGS. 19-21 show various configurations of anchoring devices shown at the second end of tension member 24. It can be appreciated that these anchoring devices could be used with each of the tension members described above. In FIG. 19, the second end of tension member 24 includes a secondary anchor 40 formed as screw which is shown augured into papillary muscle 12. FIG. 20 shows a secondary anchor 42 including a loop sewn through papillary muscle 12. FIG. 21 shows a tension member 24 extending transmurally to an exterior pad 44 to which it is connected. Tension member 24 could be sewn to pad 44 or otherwise mechanically connected thereto.


It can be appreciated that various biocompatible materials can be advantageously used to form the various components of the device of the present invention. It is anticipated that the present device will usually be chronically implanted. Thus, when selecting materials to form each of the components consideration should be given to the consequences of long term exposure of the device to tissue and tissue to the device.


Numerous characteristics and advantages of the invention covered by this document have been set forth in the foregoing description. It will be understood, however, that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of parts without exceeding the scope of the invention. The inventions's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A method of treating an in situ mitral valve, comprising: providing a valve repair device to be secured to a mitral valve annulus, the device including a basal anchor adapted to attach around at least a portion of the mitral valve annulus and having a pylon fixed thereto that extends through the mitral valve opening into the left ventricle associated with the mitral valve, the device further including tension members attached to the pylon within the left ventricle and each having a length sufficient to extend to a papillary muscle within the left ventricle, the device further including an anchor corresponding to each tension member for securing the tension member to the respective papillary muscle;delivering the device to the mitral valve annulus;anchoring the tension members to respective papillary muscles using the corresponding anchors;securing the basal anchor to the mitral valve annulus; andestablishing tension in the tension members between the respective papillary muscles and the basal anchor.
  • 2. The method of claim 1, wherein the basal anchor is crescent-shaped.
  • 3. The method of claim 2, wherein the pylon is fixed to at least two points on the basal anchor and has a spanning portion that spans between the two points and across the mitral valve opening above the basal anchor, the pylon further including a descending portion that extends through the mitral valve opening into the left ventricle associated with the mitral valve and to which the tension members attach.
  • 4. The method of claim 3, wherein the pylon further includes a perpendicular portion that bisects the spanning portion over the mitral valve opening and extends perpendicularly therefrom to a third point on the basal anchor, such that the descending portion is supported by a T-shaped structure over the mitral valve opening.
  • 5. The method of claim 1, wherein establishing tension in the tension members reduces one or both of the transverse radius and vertical dimension of the left ventricle.
  • 6. The method of claim 1, wherein establishing tension in the tension members draws the papillary muscles toward the basal anchor.
  • 7. The method of claim 1, wherein the tension members are fixably attached to the basal anchor.
  • 8. The method of claim 1, wherein the tension members are releasably attached to the basal anchor.
  • 9. The method of claim 1, further including placing a transverse tension member across the ventricular cavity and between the papillary muscles to which the tension members anchor and establishing tension in the transverse tension member directly between the papillary muscles.
  • 10. The method of claim 1, wherein the anchors for securing the tension members to the papillary muscles are transmural anchor pads.
  • 11. The method of claim 1, wherein the anchors for securing the tension members to the papillary muscles are hook-shaped papillary muscle tissue loops.
  • 12. The method of claim 1, wherein the anchors for securing the tension members to the papillary muscles are screw-shaped tissue anchors.
  • 13. The method of claim 1, wherein the tension members are substantially flexible.
  • 14. The method of claim 1, wherein the tension members are substantially rigid.
  • 15. The method of claim 1, wherein securing the basal anchor to the mitral valve annulus comprises sewing the basal anchor to the mitral valve annulus.
  • 16. The method of claim 15, wherein securing the basal anchor to the mitral valve annulus decreases the size of the annulus.
  • 17. The method of claim 1, wherein the basal anchor is an annuloplasty ring.
  • 18. A method of treating an in situ mitral valve, comprising: providing a valve repair device to be secured to a mitral valve annulus, the device including a generally planar basal anchor adapted to attach around at least a portion of the mitral valve annulus and having a pylon fixed to at least two points on the basal anchor and having a spanning portion that spans between the two points and across the mitral valve opening above the planar basal anchor, the pylon further including a descending portion that extends through the mitral valve opening into the left ventricle associated with the mitral valve;delivering the device to the mitral valve annulus;tethering a distal end of the pylon descending portion within the left ventricle to a papillary muscle using a flexible elongate member;securing the basal anchor to the mitral valve annulus; andestablishing tension in the flexible elongate member between the papillary muscle and the basal anchor.
  • 19. The method of claim 18, wherein the basal anchor is crescent-shaped.
  • 20. The method of claim 18, wherein the pylon further includes a perpendicular portion that bisects the spanning portion over the mitral valve opening and extends perpendicularly therefrom to a third point on the basal anchor, such that the descending portion is supported by a T-shaped structure over the mitral valve opening.
  • 21. The method of claim 18, wherein establishing tension in the flexible elongate member reduces one or both of the transverse radius and vertical dimension of the left ventricle.
  • 22. The method of claim 18, wherein establishing tension in the flexible elongate member draws the papillary muscle toward the basal anchor.
  • 23. The method of claim 18, wherein the flexible elongate member is fixably attached to the basal anchor.
  • 24. The method of claim 18, wherein the flexible elongate member is releasably attached to the basal anchor.
  • 25. The method of claim 18, wherein there are two flexible elongate members attached to the pylon within the left ventricle and each having a length sufficient to extend to a papillary muscle within the left ventricle.
  • 26. The method of claim 25, further including placing a transverse flexible elongate member across the ventricular cavity and between the papillary muscles to which the flexible elongate members anchor and establishing tension in the transverse flexible elongate member directly between the papillary muscles.
  • 27. The method of claim 18, wherein the device further includes an anchor for securing the flexible elongate member to the papillary muscle.
  • 28. The method of claim 27, wherein the anchor is a transmural anchor pad.
  • 29. The method of claim 27, wherein the anchor is a hook-shaped papillary muscle tissue loop.
  • 30. The method of claim 27, wherein the anchor is a screw-shaped tissue anchor.
  • 31. The method of claim 18, wherein the flexible elongate member is substantially flexible.
  • 32. The method of claim 18, wherein the flexible elongate member is substantially rigid.
  • 33. The method of claim 18, wherein securing the basal anchor to the mitral valve annulus comprises sewing the basal anchor to the mitral valve annulus.
  • 34. The method of claim 33, wherein securing the basal anchor to the mitral valve annulus decreases the size of the annulus.
  • 35. The method of claim 18, wherein the basal anchor is an annuloplasty ring.
CROSS-REFERENCE TO RELATED APPLICATIONS

This is a continuation of application Ser. No. 09/981,790, filed Oct. 19, 2001, now pending, which is a continuation of application Ser. No. 08/992,316, filed Dec. 17, 1997, now U.S. Pat. No. 6,332,893, both of which are incorporated herein by reference.

US Referenced Citations (615)
Number Name Date Kind
963899 Kistler Jul 1910 A
3019790 Militana Feb 1962 A
3656185 Carpentier Apr 1972 A
3980086 Kletschka et al. Sep 1976 A
4035849 Angell et al. Jul 1977 A
4055861 Carpentier et al. Nov 1977 A
4192293 Asrican Mar 1980 A
4217665 Bex et al. Aug 1980 A
4261342 Aranguren Duo Apr 1981 A
4300564 Furihata Nov 1981 A
4306319 Kaster Dec 1981 A
4343048 Ross et al. Aug 1982 A
4372293 Vijil-Rosales Feb 1983 A
4409974 Freedland Oct 1983 A
4536893 Parravicini Aug 1985 A
4579120 MacGregor Apr 1986 A
4592342 Salmasian Jun 1986 A
4629459 Ionescu et al. Dec 1986 A
4632101 Freedland Dec 1986 A
4690134 Snyders Sep 1987 A
4705040 Mueller et al. Nov 1987 A
4936857 Kulik Jun 1990 A
4944753 Burgess et al. Jul 1990 A
4960424 Grooters Oct 1990 A
4991578 Cohen Feb 1991 A
4997431 Isner et al. Mar 1991 A
5061277 Carpentier et al. Oct 1991 A
5104407 Lam et al. Apr 1992 A
5106386 Isner et al. Apr 1992 A
5131905 Grooters Jul 1992 A
RE34021 Mueller et al. Aug 1992 E
5152765 Ross et al. Oct 1992 A
5156621 Navia et al. Oct 1992 A
5169381 Snyders Dec 1992 A
5192314 Daskalakis Mar 1993 A
5250049 Michael Oct 1993 A
5256132 Snyders Oct 1993 A
5258015 Li et al. Nov 1993 A
5284488 Sideris Feb 1994 A
5300087 Knoepfler Apr 1994 A
5312642 Chesterfield et al. May 1994 A
5360444 Kusuhara Nov 1994 A
5376112 Duren Dec 1994 A
5383840 Heilman et al. Jan 1995 A
5385528 Wilk Jan 1995 A
5389096 Aita et al. Feb 1995 A
5397331 Himpens et al. Mar 1995 A
5417709 Slater May 1995 A
5433727 Sideris Jul 1995 A
5445600 Abdulla Aug 1995 A
5450860 O'Connor Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5458574 Machold et al. Oct 1995 A
5496305 Kittrell et al. Mar 1996 A
5509428 Dunlop Apr 1996 A
5522884 Wright Jun 1996 A
5533958 Wilk Jul 1996 A
5571215 Sterman et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5593424 Northrup, III Jan 1997 A
5607471 Seguin et al. Mar 1997 A
5655548 Nelson et al. Aug 1997 A
5665092 Mangiardi et al. Sep 1997 A
5674279 Wright et al. Oct 1997 A
5682906 Sterman et al. Nov 1997 A
5702343 Alferness Dec 1997 A
5713954 Rosenberg et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5738649 Macoviak Apr 1998 A
5755783 Stobie et al. May 1998 A
5758663 Wilk et al. Jun 1998 A
5766234 Chen et al. Jun 1998 A
5776189 Khalid et al. Jul 1998 A
5800334 Wilk Sep 1998 A
5800528 Lederman et al. Sep 1998 A
5800531 Cosgrove et al. Sep 1998 A
5807384 Mueller Sep 1998 A
5814097 Sterman et al. Sep 1998 A
5824066 Gross Oct 1998 A
5824069 Lemole Oct 1998 A
5840059 March et al. Nov 1998 A
5849005 Garrison et al. Dec 1998 A
5855601 Bessler et al. Jan 1999 A
5855614 Stevens et al. Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5876436 Vanney et al. Mar 1999 A
5888240 Carpentier et al. Mar 1999 A
5902229 Tsitlik et al. May 1999 A
5928281 Huynh et al. Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5957977 Melvin Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5961539 Northrup, III et al. Oct 1999 A
5961549 Nguyen et al. Oct 1999 A
5967990 Thierman et al. Oct 1999 A
5971910 Tsitlik et al. Oct 1999 A
5971911 Wilk Oct 1999 A
5972022 Huxel Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5984857 Buck et al. Nov 1999 A
5984917 Fleischman et al. Nov 1999 A
5999678 Murphy-Chutorian et al. Dec 1999 A
6001126 Nguyen-Thien-Nhon Dec 1999 A
6019722 Spence et al. Feb 2000 A
6024096 Buckberg Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6050936 Schweich, Jr. et al. Apr 2000 A
6059715 Schweich, Jr. et al. May 2000 A
6071303 Laufer Jun 2000 A
6077214 Mortier et al. Jun 2000 A
6077218 Alferness Jun 2000 A
6079414 Roth Jun 2000 A
6085754 Alferness et al. Jul 2000 A
6086532 Panescu et al. Jul 2000 A
6095968 Snyders Aug 2000 A
6102944 Huynh et al. Aug 2000 A
6110100 Talpade Aug 2000 A
6113536 Aboul-Hosn et al. Sep 2000 A
6113636 Ogle Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6120520 Saadat et al. Sep 2000 A
6123662 Alferness et al. Sep 2000 A
6125852 Stevens et al. Oct 2000 A
6126590 Alferness Oct 2000 A
6129758 Love Oct 2000 A
6132438 Fleischman et al. Oct 2000 A
6143025 Stobie et al. Nov 2000 A
6155968 Wilk Dec 2000 A
6155972 Nauertz et al. Dec 2000 A
6162168 Schweich, Jr. et al. Dec 2000 A
6165119 Schweich, Jr. et al. Dec 2000 A
6165120 Schweich, Jr. et al. Dec 2000 A
6165121 Alferness Dec 2000 A
6165122 Alferness Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6169922 Alferness et al. Jan 2001 B1
6174279 Girard Jan 2001 B1
6174332 Loch et al. Jan 2001 B1
6179791 Krueger Jan 2001 B1
6182664 Cosgrove Feb 2001 B1
6183411 Mortier et al. Feb 2001 B1
6183512 Howanec, Jr. et al. Feb 2001 B1
6190408 Malvin Feb 2001 B1
6193648 Krueger Feb 2001 B1
6197053 Cosgrove et al. Mar 2001 B1
6206004 Schmidt et al. Mar 2001 B1
6206820 Kazi et al. Mar 2001 B1
6210432 Solem et al. Apr 2001 B1
6217610 Carpentier et al. Apr 2001 B1
6221013 Panescu et al. Apr 2001 B1
6221103 Melvin Apr 2001 B1
6221104 Buckberg et al. Apr 2001 B1
6224540 Lederman et al. May 2001 B1
6230714 Alferness et al. May 2001 B1
6231561 Frazier et al. May 2001 B1
6231602 Carpentier et al. May 2001 B1
6238334 Easterbrook, III et al. May 2001 B1
6241654 Alferness Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6245105 Nguyen et al. Jun 2001 B1
6250308 Cox Jun 2001 B1
6251061 Hastings et al. Jun 2001 B1
6258021 Wilk Jul 2001 B1
6258023 Rogers et al. Jul 2001 B1
6260552 Mortier et al. Jul 2001 B1
6260820 Chowdhury Jul 2001 B1
6261222 Schweich, Jr. et al. Jul 2001 B1
6264602 Mortier et al. Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6283993 Cosgrove et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6293906 Vanden Hoek et al. Sep 2001 B1
6309370 Haim et al. Oct 2001 B1
6312447 Grimes Nov 2001 B1
6314322 Rosenberg Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6331157 Hancock Dec 2001 B2
6332863 Schweich, Jr. et al. Dec 2001 B1
6332864 Schweich, Jr. et al. Dec 2001 B1
6332893 Mortier et al. Dec 2001 B1
6338712 Spence et al. Jan 2002 B2
6343605 Lafontaine Feb 2002 B1
6360749 Jayaraman Mar 2002 B1
6361545 Macoviak Mar 2002 B1
6370429 Alferness et al. Apr 2002 B1
6375608 Alferness Apr 2002 B1
6379366 Fleischman et al. Apr 2002 B1
6402679 Mortier et al. Jun 2002 B1
6402680 Mortier et al. Jun 2002 B2
6402781 Langberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6406422 Landesberg Jun 2002 B1
6409759 Peredo Jun 2002 B1
6409760 Melvin Jun 2002 B1
6416459 Haindl Jul 2002 B1
6419669 Frazier et al. Jul 2002 B1
6425856 Shapland et al. Jul 2002 B1
6432039 Wardle Aug 2002 B1
6432059 Hickey Aug 2002 B2
6436088 Frazier et al. Aug 2002 B2
6439237 Buckberg et al. Aug 2002 B1
6443949 Altman Sep 2002 B2
6450171 Buckberg et al. Sep 2002 B1
6458100 Roue et al. Oct 2002 B2
6461366 Seguin Oct 2002 B1
6478729 Rogers et al. Nov 2002 B1
6482146 Alferness et al. Nov 2002 B1
6488706 Solymar Dec 2002 B1
6494825 Talpade Dec 2002 B1
6511426 Hossack et al. Jan 2003 B1
8756131 Kung et al. Jan 2003
6514194 Schweich, Jr. et al. Feb 2003 B2
6520904 Melvin Feb 2003 B1
6537198 Vidlund et al. Mar 2003 B1
6537203 Alferness et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6544167 Buckberg et al. Apr 2003 B2
6544180 Doten et al. Apr 2003 B1
6547821 Taylor et al. Apr 2003 B1
6569198 Wilson et al. May 2003 B1
6572529 Wilk Jun 2003 B2
6582355 Alferness et al. Jun 2003 B2
6587734 Okuzumi Jul 2003 B2
6589160 Schweich, Jr. et al. Jul 2003 B2
6592619 Melvin Jul 2003 B2
6595912 Lau et al. Jul 2003 B2
6602182 Milbocker Aug 2003 B1
6602184 Lau et al. Aug 2003 B2
6612278 Kampichler Sep 2003 B2
6612978 Lau et al. Sep 2003 B2
6612979 Lau et al. Sep 2003 B2
6616596 Milbocker Sep 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6619291 Hlavka Sep 2003 B2
6622730 Ekvall et al. Sep 2003 B2
6626821 Kung et al. Sep 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6645139 Haindl Nov 2003 B2
6651671 Donlon et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6663558 Lau et al. Dec 2003 B2
6673009 Vanden Hoek et al. Jan 2004 B1
6676702 Mathis Jan 2004 B2
6681773 Murphy et al. Jan 2004 B2
6682474 Lau et al. Jan 2004 B2
6682475 Cox et al. Jan 2004 B2
6682476 Alferness et al. Jan 2004 B2
6685620 Gifford, III et al. Feb 2004 B2
6685627 Jayaraman Feb 2004 B2
6685646 Cespedes et al. Feb 2004 B2
6689048 Vanden Hoek et al. Feb 2004 B2
6695768 Levine et al. Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6701929 Hussein Mar 2004 B2
6702732 Lau et al. Mar 2004 B1
6702763 Murphy et al. Mar 2004 B2
6702826 Liddicoat et al. Mar 2004 B2
6706065 Langberg et al. Mar 2004 B2
6709456 Langberg et al. Mar 2004 B2
6712804 Roue et al. Mar 2004 B2
6716158 Raman et al. Apr 2004 B2
6719767 Kimblad Apr 2004 B1
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6730016 Cox et al. May 2004 B1
6733525 Yang et al. May 2004 B2
6740107 Loeb et al. May 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755777 Schweich, Jr. et al. Jun 2004 B2
6755779 Vanden Hoek et al. Jun 2004 B2
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6776754 Wilk Aug 2004 B1
6790231 Liddicoat et al. Sep 2004 B2
6793673 Kowalsky et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6800090 Alferness et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6810882 Langberg et al. Nov 2004 B2
6814700 Mueller et al. Nov 2004 B1
6824562 Mathis et al. Nov 2004 B2
6830585 Artof et al. Dec 2004 B1
6837247 Buckberg et al. Jan 2005 B2
6846296 Milbocker et al. Jan 2005 B1
6858039 McCarthy Feb 2005 B2
6875224 Grimes Apr 2005 B2
6876887 Okuzumi Apr 2005 B2
6881185 Vanden Hock et al. Apr 2005 B2
6887192 Whayne et al. May 2005 B1
6890353 Cohn et al. May 2005 B2
6893392 Alferness May 2005 B2
6896652 Alferness et al. May 2005 B2
6902522 Walsh et al. Jun 2005 B1
6908426 Shapland et al. Jun 2005 B2
6908478 Alferness et al. Jun 2005 B2
6913608 Liddicoat et al. Jul 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6921407 Nguyen et al. Jul 2005 B2
6949122 Adams et al. Sep 2005 B2
6951534 Girard et al. Oct 2005 B2
6955689 Ryan et al. Oct 2005 B2
6959711 Murphy et al. Nov 2005 B2
6960229 Mathis et al. Nov 2005 B2
6962605 Cosgrove et al. Nov 2005 B2
6966926 Mathis Nov 2005 B2
6976995 Mathis et al. Dec 2005 B2
7163507 Alferness Jan 2007 B2
7166071 Alferness Jan 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7255674 Alferness Aug 2007 B2
7261684 Alferness Aug 2007 B2
7278964 Alferness Oct 2007 B2
7351200 Alferness Apr 2008 B2
20010003986 Cosgrove Jun 2001 A1
20010005787 Oz et al. Jun 2001 A1
20010009976 Panescu et al. Jul 2001 A1
20010014800 Frazier et al. Aug 2001 A1
20010014811 Hussein Aug 2001 A1
20010018611 Solem et al. Aug 2001 A1
20010021874 Carpentier et al. Sep 2001 A1
20010029314 Alferness et al. Oct 2001 A1
20010034551 Cox Oct 2001 A1
20010037123 Hancock Nov 2001 A1
20010039434 Frazier et al. Nov 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041821 Wilk Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20010047122 Vanden Hoek et al. Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020007216 Melvin Jan 2002 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020016628 Langberg et al. Feb 2002 A1
20020019580 Lau et al. Feb 2002 A1
20020022880 Melvin Feb 2002 A1
20020026092 Buckberg et al. Feb 2002 A1
20020028981 Lau et al. Mar 2002 A1
20020029783 Stevens et al. Mar 2002 A1
20020032364 Lau et al. Mar 2002 A1
20020042554 Alferness et al. Apr 2002 A1
20020045798 Lau et al. Apr 2002 A1
20020045799 Lau et al. Apr 2002 A1
20020045800 Lau et al. Apr 2002 A1
20020052538 Lau et al. May 2002 A1
20020056461 Jayaraman May 2002 A1
20020058855 Schweich, Jr. et al. May 2002 A1
20020065449 Wardle May 2002 A1
20020065465 Panescu et al. May 2002 A1
20020065554 Streeter May 2002 A1
20020068850 Vanden Hoek et al. Jun 2002 A1
20020077532 Gannoe et al. Jun 2002 A1
20020082647 Alferness et al. Jun 2002 A1
20020087173 Alferness et al. Jul 2002 A1
20020091296 Alferness Jul 2002 A1
20020103511 Alferness et al. Aug 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020103533 Langberg et al. Aug 2002 A1
20020111533 Melvin Aug 2002 A1
20020111567 Vanden Hoek et al. Aug 2002 A1
20020111636 Fleischman et al. Aug 2002 A1
20020133055 Haindl Sep 2002 A1
20020143250 Panescu et al. Oct 2002 A1
20020151766 Shapland et al. Oct 2002 A1
20020151961 Lashinski et al. Oct 2002 A1
20020161275 Schweich, Jr. et al. Oct 2002 A1
20020169358 Mortier et al. Nov 2002 A1
20020169359 McCarthy et al. Nov 2002 A1
20020169360 Taylor et al. Nov 2002 A1
20020169502 Mathis Nov 2002 A1
20020169504 Alferness et al. Nov 2002 A1
20020173694 Mortier et al. Nov 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20020183836 Liddicoat et al. Dec 2002 A1
20020183837 Streeter et al. Dec 2002 A1
20020183838 Liddicoat et al. Dec 2002 A1
20020183841 Cohn et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020188350 Arru et al. Dec 2002 A1
20030004396 Vanden Hock et al. Jan 2003 A1
20030009081 Rogers et al. Jan 2003 A1
20030023132 Melvin et al. Jan 2003 A1
20030028077 Alferness et al. Feb 2003 A1
20030032979 Mortier et al. Feb 2003 A1
20030045771 Schweich, Jr. et al. Mar 2003 A1
20030045776 Alferness et al. Mar 2003 A1
20030045896 Murphy et al. Mar 2003 A1
20030050529 Vidlund et al. Mar 2003 A1
20030050659 Murphy et al. Mar 2003 A1
20030060674 Gifford, III et al. Mar 2003 A1
20030065248 Lau et al. Apr 2003 A1
20030069467 Lau et al. Apr 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078653 Vesely et al. Apr 2003 A1
20030078671 Lesniak et al. Apr 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030130730 Cohn et al. Jul 2003 A1
20030130731 Vidlund et al. Jul 2003 A1
20030144697 Mathis et al. Jul 2003 A1
20030149333 Alferness Aug 2003 A1
20030153946 Kimblad Aug 2003 A1
20030158570 Ferrazzi Aug 2003 A1
20030166992 Schweich, Jr. et al. Sep 2003 A1
20030171641 Schweich, Jr. et al. Sep 2003 A1
20030171776 Adams et al. Sep 2003 A1
20030171806 Mathis et al. Sep 2003 A1
20030181928 Vidlund et al. Sep 2003 A1
20030191538 Buckberg et al. Oct 2003 A1
20030199733 Shapland et al. Oct 2003 A1
20030212453 Mathis et al. Nov 2003 A1
20030225454 Mathis et al. Dec 2003 A1
20030229260 Girard et al. Dec 2003 A1
20030229261 Girard et al. Dec 2003 A1
20030229265 Girard et al. Dec 2003 A1
20030229266 Cox et al. Dec 2003 A1
20030233022 Vidlund et al. Dec 2003 A1
20030233142 Morales et al. Dec 2003 A1
20030236569 Mathis et al. Dec 2003 A1
20040002719 Oz et al. Jan 2004 A1
20040003819 St. Goar et al. Jan 2004 A1
20040010305 Alferness et al. Jan 2004 A1
20040015039 Melvin Jan 2004 A1
20040015040 Melvin Jan 2004 A1
20040015041 Melvin Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024286 Melvin Feb 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040034271 Melvin et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040039443 Solem et al. Feb 2004 A1
20040044365 Bachman Mar 2004 A1
20040049115 Murphy et al. Mar 2004 A1
20040049116 Murphy et al. Mar 2004 A1
20040059180 Melvin Mar 2004 A1
20040059181 Alferness Mar 2004 A1
20040059182 Alferness Mar 2004 A1
20040059187 Alferness Mar 2004 A1
20040059188 Alferness Mar 2004 A1
20040059189 Alferness Mar 2004 A1
20040059351 Eigler et al. Mar 2004 A1
20040064014 Melvin et al. Apr 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040092962 Thornton et al. May 2004 A1
20040093023 Allen et al. May 2004 A1
20040098116 Callas et al. May 2004 A1
20040102678 Haindl May 2004 A1
20040102679 Alferness et al. May 2004 A1
20040102839 Cohn et al. May 2004 A1
20040102840 Solem et al. May 2004 A1
20040111095 Gordon et al. Jun 2004 A1
20040111101 Chin Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040122512 Navia et al. Jun 2004 A1
20040122513 Navia et al. Jun 2004 A1
20040127980 Kowalsky et al. Jul 2004 A1
20040127981 Rahdert et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133062 Pai et al. Jul 2004 A1
20040133063 McCarthy et al. Jul 2004 A1
20040133069 Shapland et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133240 Adams et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138526 Guenst Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040143323 Chawla Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040152947 Schroeder et al. Aug 2004 A1
20040158123 Jayaraman Aug 2004 A1
20040158321 Reuter Aug 2004 A1
20040162610 Liska et al. Aug 2004 A1
20040167374 Schweich et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040171907 Alferness et al. Sep 2004 A1
20040171908 Alferness et al. Sep 2004 A1
20040171909 Alferness Sep 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040176678 Murphy et al. Sep 2004 A1
20040176679 Murphy et al. Sep 2004 A1
20040176840 Langberg et al. Sep 2004 A1
20040181121 Alferness et al. Sep 2004 A1
20040181122 Alferness et al. Sep 2004 A1
20040181123 Alferness et al. Sep 2004 A1
20040181124 Alferness Sep 2004 A1
20040181125 Alferness et al. Sep 2004 A1
20040181126 Buckberg et al. Sep 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040186342 Vanden Hock et al. Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040193260 Alferness et al. Sep 2004 A1
20040199183 Oz et al. Oct 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210240 Saint Oct 2004 A1
20040210303 Sedransk Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210306 Quijano et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040220593 Greenhalgh Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040243227 Starlksen et al. Dec 2004 A1
20040243228 Kowalsky et al. Dec 2004 A1
20040243229 Vidlund et al. Dec 2004 A1
20040249452 Adams et al. Dec 2004 A1
20040254600 Zarbatany et al. Dec 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040267083 McCarthy et al. Dec 2004 A1
20040267329 Raman et al. Dec 2004 A1
20040267358 Reitan Dec 2004 A1
20050004428 Cox et al. Jan 2005 A1
20050004665 Aklog Jan 2005 A1
20050004666 Alfieri et al. Jan 2005 A1
20050004667 Swinford et al. Jan 2005 A1
20050004668 Aklog et al. Jan 2005 A1
20050010240 Mathis et al. Jan 2005 A1
20050010283 Vijay Jan 2005 A1
20050010286 Vijay Jan 2005 A1
20050021056 St. Goar et al. Jan 2005 A1
20050021057 St. Goar et al. Jan 2005 A1
20050021121 Reuter et al. Jan 2005 A1
20050021135 Ryan et al. Jan 2005 A1
20050027351 Reuter et al. Feb 2005 A1
20050027353 Alferness et al. Feb 2005 A1
20050027369 Eldridge et al. Feb 2005 A1
20050033419 Alferness et al. Feb 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050038506 Webler et al. Feb 2005 A1
20050038507 Alferness et al. Feb 2005 A1
20050038509 Ashe Feb 2005 A1
20050043792 Solem et al. Feb 2005 A1
20050049679 Taylor et al. Mar 2005 A1
20050049698 Bolling et al. Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050059854 Vanden Hoek et al. Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065550 Starlsen et al. Mar 2005 A1
20050065598 Mathis et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050070998 Rourke et al. Mar 2005 A1
20050071000 Liddicoat et al. Mar 2005 A1
20050075723 Schroeder et al. Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050080402 Santamore et al. Apr 2005 A1
20050080483 Solem et al. Apr 2005 A1
20050085688 Girard et al. Apr 2005 A1
20050095268 Walsh et al. May 2005 A1
20050096666 Gordon et al. May 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107810 Morales et al. May 2005 A1
20050107811 Starksen et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050113635 Whayne et al. May 2005 A1
20050113811 Houser et al. May 2005 A1
20050119519 Girard et al. Jun 2005 A9
20050131533 Alfier et al. Jun 2005 A1
20050137449 Nieminen et al. Jun 2005 A1
20050137450 Aronson et al. Jun 2005 A1
20050137451 Gordon et al. Jun 2005 A1
20050137685 Nieminen et al. Jun 2005 A1
20050137700 Spence et al. Jun 2005 A1
20050143811 Realyvasquez Jun 2005 A1
20050149179 Mathis et al. Jul 2005 A1
20050149180 Mathis et al. Jul 2005 A1
20050149182 Alferness et al. Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050184122 Hlavka et al. Aug 2005 A1
20050187619 Mathis et al. Aug 2005 A1
20050192474 Vanden Hoek et al. Sep 2005 A1
20050192666 McCarthy Sep 2005 A1
20050197527 Bolling Sep 2005 A1
20050197528 Vanden Hoek et al. Sep 2005 A1
20050197692 Pai et al. Sep 2005 A1
20050197693 Pai et al. Sep 2005 A1
20050209690 Mathis et al. Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216077 Mathis et al. Sep 2005 A1
20050216078 Starksen et al. Sep 2005 A1
20050222488 Chang et al. Oct 2005 A1
20050222489 Rahdert et al. Oct 2005 A1
20050222678 Lashinski et al. Oct 2005 A1
20050228217 Alferness et al. Oct 2005 A1
20050228422 Machold et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050246014 McCarthy Nov 2005 A1
20050256567 Lim et al. Nov 2005 A1
20050256568 Lim et al. Nov 2005 A1
20050256569 Lim et al. Nov 2005 A1
20050261704 Mathis et al. Nov 2005 A1
20050267574 Cohn et al. Dec 2005 A1
20050272969 Alferness et al. Dec 2005 A1
20050278022 Lim Dec 2005 A1
20060004443 Liddicoat et al. Jan 2006 A1
20060009842 Huynh et al. Jan 2006 A1
20060030885 Hyde Feb 2006 A1
20060036317 Vidlund et al. Feb 2006 A1
20060041306 Vidlund et al. Feb 2006 A1
20060052868 Mortier et al. Mar 2006 A1
20060100699 Vidlund et al. May 2006 A1
20060161040 McCarthy et al. Jul 2006 A1
20060195012 Mortier et al. Aug 2006 A1
20070004962 Alferness et al. Jan 2007 A1
20070112244 McCarthy et al. May 2007 A1
20070225547 Alferness Sep 2007 A1
Foreign Referenced Citations (117)
Number Date Country
32 27 984 Feb 1984 DE
36 14 292 Nov 1987 DE
42 34 127 May 1994 DE
295 00 381 Jul 1995 DE
296 18 925 Jan 1997 DE
296 19 294 Aug 1997 DE
298 24 017 Jun 1998 DE
198 26 675 Mar 1999 DE
199 47 885 Apr 2000 DE
0 583 012 Feb 1994 EP
0 792 621 Sep 1997 EP
0 820 729 Jan 1998 EP
1 129 736 Sep 2001 EP
2214428 Sep 1989 GB
9 200 878 Dec 1993 NL
1335260 Feb 1989 SU
WO 9119465 Dec 1991 WO
WO 9506447 Mar 1995 WO
WO 9516407 Jun 1995 WO
WO 9516476 Jun 1995 WO
WO 9602197 Feb 1996 WO
WO 9604852 Feb 1996 WO
WO 9640356 Dec 1996 WO
WO 9714286 Apr 1997 WO
WO 9724082 Jul 1997 WO
WO 9724083 Jul 1997 WO
WO 9724101 Jul 1997 WO
WO 9741779 Nov 1997 WO
WO 9803213 Jan 1998 WO
WO 9814136 Apr 1998 WO
WO 9817347 Apr 1998 WO
WO 9818393 May 1998 WO
WO 9826738 Jun 1998 WO
WO 9829041 Jul 1998 WO
WO 9832382 Jul 1998 WO
WO 9844969 Oct 1998 WO
WO 9858598 Dec 1998 WO
WO 9900059 Jan 1999 WO
WO 9911201 Mar 1999 WO
WO 9913777 Mar 1999 WO
WO 9913936 Mar 1999 WO
WO 9916350 Apr 1999 WO
WO 9922784 May 1999 WO
WO 9930647 Jun 1999 WO
WO 9944534 Sep 1999 WO
WO 9944680 Sep 1999 WO
WO 9952470 Oct 1999 WO
WO 9953977 Oct 1999 WO
WO 9956655 Nov 1999 WO
WO 9962727 Dec 1999 WO
WO 9966969 Dec 1999 WO
WO 0002500 Jan 2000 WO
WO 0003759 Jan 2000 WO
WO 0006026 Feb 2000 WO
WO 0006028 Feb 2000 WO
WO 0013722 Mar 2000 WO
WO 0018320 Apr 2000 WO
WO 0025842 May 2000 WO
WO 0025853 May 2000 WO
WO 0027304 May 2000 WO
WO 0028912 May 2000 WO
WO 0028918 May 2000 WO
WO 0036995 Jun 2000 WO
WO 0042919 Jul 2000 WO
WO 0042950 Jul 2000 WO
WO 0042951 Jul 2000 WO
WO 0045735 Aug 2000 WO
WO 0060995 Oct 2000 WO
WO 0061033 Oct 2000 WO
WO 0062715 Oct 2000 WO
WO 0100111 Jan 2001 WO
WO 0103608 Jan 2001 WO
WO 0119291 Mar 2001 WO
WO 0119292 Mar 2001 WO
WO 0121070 Mar 2001 WO
WO 0121098 Mar 2001 WO
WO 0121099 Mar 2001 WO
WO 0121247 Mar 2001 WO
WO 0154562 Mar 2001 WO
WO 0195832 Mar 2001 WO
WO 0126557 Apr 2001 WO
WO 0128432 Apr 2001 WO
WO 0149217 Jul 2001 WO
WO 0150981 Jul 2001 WO
WO 0154618 Aug 2001 WO
WO 0154745 Aug 2001 WO
WO 0167985 Sep 2001 WO
WO 0170116 Sep 2001 WO
WO 0178625 Oct 2001 WO
WO 0185061 Nov 2001 WO
WO 0191667 Dec 2001 WO
WO 0195830 Dec 2001 WO
WO 0195831 Dec 2001 WO
WO 0211625 Feb 2002 WO
WO 0213726 Feb 2002 WO
WO 0219917 Mar 2002 WO
WO 0228450 Apr 2002 WO
WO 0230292 Apr 2002 WO
WO 0230335 Apr 2002 WO
WO 0234167 May 2002 WO
WO 0238081 May 2002 WO
WO 0243617 Jun 2002 WO
WO 02053206 Jul 2002 WO
WO 02060352 Aug 2002 WO
WO 02062263 Aug 2002 WO
WO 02062270 Aug 2002 WO
WO 02062408 Aug 2002 WO
WO 02064035 Aug 2002 WO
WO 02076284 Oct 2002 WO
WO 02078576 Oct 2002 WO
WO 02085251 Oct 2002 WO
WO 02096275 Dec 2002 WO
WO 03001893 Jan 2003 WO
WO 03007778 Jan 2003 WO
WO 03015611 Feb 2003 WO
WO 03022131 Mar 2003 WO
WO 03059209 Jul 2003 WO
Related Publications (1)
Number Date Country
20060052868 A1 Mar 2006 US
Continuations (2)
Number Date Country
Parent 09981790 Oct 2001 US
Child 11172437 US
Parent 08992316 Dec 1997 US
Child 09981790 US